Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Renal Histopathological Findings in Patients with Renal Allograft Dysfunction: A Retrospective Single Center Study.

Iranian journal of kidney diseases·2023
Same author

Percutaneous biopsy of kidney; comparison between prone position and sitting position.

Iranian journal of kidney diseases·2019
Same author

Vitamin D Supplementation and Risk of Hypercalciuria in Stone Formers.

Iranian journal of kidney diseases·2019
Same author

Action plan for determining and monitoring the prevalence of chronic kidney disease.

Kidney international supplements·2019
Same author

The establishment and validation of novel therapeutic targets to retard progression of chronic kidney disease.

Kidney international supplements·2019
Same author

Association between low bone mass and the serum RANKL and OPG in patients with nephrolithiasis.

BMC nephrology·2018

Related Experiment Video

Updated: May 24, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Chronic allograft dysfunction: major contributing factors.

Mohammad Reza Ganji1, Abdolreza Harririan

  • 1Department of Nephrology and Transplantation, Dr Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran. mrezaganji@yahoo.com

Iranian Journal of Kidney Diseases
|March 6, 2012
PubMed
Summary
This summary is machine-generated.

Chronic allograft dysfunction (CAD) leads to kidney transplant failure. Identifying at-risk patients and optimizing immunosuppression can improve long-term outcomes for kidney transplant recipients.

Related Experiment Videos

Last Updated: May 24, 2026

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

Area of Science:

  • Nephrology
  • Transplantation Immunology

Background:

  • Chronic allograft dysfunction (CAD) is the primary cause of kidney transplant failure.
  • CAD involves progressive interstitial fibrosis and tubular atrophy, driven by immunological and non-immunological factors.

Purpose of the Study:

  • To review the multifactorial nature of chronic allograft dysfunction.
  • To highlight factors contributing to fibrosis and atrophy in kidney allografts.
  • To discuss strategies for improving long-term kidney transplant outcomes.

Main Methods:

  • Review of current data on chronic allograft dysfunction.
  • Analysis of immunological and non-immunological factors.
  • Discussion of calcineurin inhibitor effects and late-stage allograft injury.

Main Results:

  • CAD is a complex process involving acute and chronic rejection, infections, and calcineurin inhibitor-associated nephrotoxicity.
  • Early fibrotic changes can occur but late-stage factors are critical for progressive dysfunction.
  • Chronic antibody-mediated rejection and glomerulonephritis are key contributors to fibrosis after one year.

Conclusions:

  • Optimizing immunosuppression and close monitoring are crucial for managing CAD.
  • Individualized treatment strategies are needed to mitigate risks and improve graft survival.
  • Early identification of at-risk patients is essential for proactive management of kidney allograft dysfunction.